Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice1,2

Transplantation

Volumn 70, Issue 12, 2000, Pages 1771-1780

  Bumgardner, Ginny L ^a,b,c   Gao, Donghong ^a   Li, Jiashun ^a   Baskin, Joseph H ^a   Heininger, Marie ^a   Orosz, Charles G ^a,b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; LIVER TRANSPLANTATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SCID MOUSE; SURVIVAL TIME;

EID: 0034722913     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200012270-00017     Document Type: Article

References (43)

1. Costimulation pathways in host immune responses to allogeneic hepatocytes
2. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model
3. A functional model of hepatocyte transplantation for in vivo immunologic studies
4. + T-cell responses in acute rejection
5. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response
6. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody
7. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody
8. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model
9. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy
10. Prolonged murine cardiac allograft acceptance: Characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody
11. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
12. Blocking the CD28-B7 T lymphocyte costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4
13. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway
14. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
15. Transplantation tolerance induced by CTLA4-lg
16. CD4+ but not CD8+ cells are essential for allorejection
17. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes
18. Preparation of rat liver parenchymal cells: Enzymatic requirements for tissue dispersion
19. Preparation of isolated rat liver cells
20. Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection
21. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice
22. Afferent and efferent pathways in T cell responses to MHC class I + class II- hepatocytes
23. Comparison of in vivo and in vitro immune response to purified hepatocytes
24. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. 1. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte sponge matrix allografts
25. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes
26. An increase in the survival of murine H-2- mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine
27. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation
28. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolermace when pretreatment is combined with anti-Cd4 monoclonal antibody
29. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4
30. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts
31. A new foreign policy: MHC class I molecules monitor the outside world
32. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
33. CTLA4-Ig and anti-CD40 ligand prevent renal allograft, rejection in primates
34. Immunomodulation of pancreatic islet allografts in mice with CTLA-4Ig secreting muscle cells
35. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model
36. CTLA-4Ig prolongs allograft survival while suppressing cell-mediated immunity
37. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4-Ig plus donor-specific transfusion
38. Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4-Ig
39. Alloreactive delayed-type hypersensitivity in graft, recipients: Complexity of responses and divergence from acute rejection
40. Patterns of allosensitization in allograft recipients: Long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity
41. Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft, rejection mediated by CD4+ but not CD8+ T cells
42. The role of CD8 and CD4 T cells in intestinal allograft rejection: A comparison of monoclonal antibody-treated and knockout mice
43. Vigorous allograft, rejection in the absence of danger